Request Demo
Last update 25 Mar 2026
CD19/BCMA-targeted CAR-T lentiviral vector drug(Shenzhen Genocury Biotech)
Last update 25 Mar 2026
Overview
Basic Info
Drug Type in vivo CAR-T therapy |
Synonyms- |
Target |
Action modulators |
Mechanism BCMA modulators(B-cell maturation protein modulators), CD19 modulators(B-lymphocyte antigen CD19 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseClinical |
First Approval Date- |
Regulation- |
Related
1
Clinical Trials associated with CD19/BCMA-targeted CAR-T lentiviral vector drug(Shenzhen Genocury Biotech)NCT07490951
A Clinical Study on the Safety, Tolerability and Preliminary Efficacy of Targeted CD19/BCMA CAR-T Therapy in the Treatment of Refractory Autoimmune Diseases (ADs)
100 Clinical Results associated with CD19/BCMA-targeted CAR-T lentiviral vector drug(Shenzhen Genocury Biotech)
Login to view more data
100 Translational Medicine associated with CD19/BCMA-targeted CAR-T lentiviral vector drug(Shenzhen Genocury Biotech)
Login to view more data
100 Patents (Medical) associated with CD19/BCMA-targeted CAR-T lentiviral vector drug(Shenzhen Genocury Biotech)
Login to view more data
100 Deals associated with CD19/BCMA-targeted CAR-T lentiviral vector drug(Shenzhen Genocury Biotech)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Churg-Strauss Syndrome | Clinical | China | 22 Mar 2026 | |
| Granulomatosis With Polyangiitis | Clinical | China | 22 Mar 2026 | |
| Microscopic Polyangiitis | Clinical | China | 22 Mar 2026 | |
| Scleroderma, Systemic | Clinical | China | 22 Mar 2026 | |
| Sjogren's Syndrome | Clinical | China | 22 Mar 2026 | |
| Systemic Lupus Erythematosus | Clinical | China | 22 Mar 2026 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free